Consumer Reports: Alzheimer's drugs are costly, ineffective

01/8/2013 | Washington Post, The

Drugs approved to treat Alzheimer's disease are expensive and are not really effective for many patients, according to Consumer Reports Best Buy Drugs. The report said none of the drugs could be considered a "Best Buy," based on analyses from several health care organizations, and that they had side effects that could be debilitating for older patients.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Chief Executive Officer
UCare Minnesota
Minneapolis, MN